Company intelligence / Profile preview

Concentra AI

Ownership: Private
Development stage: Preclinical

Overview

Concentra Biosciences is an active investment firm under Tang Capital Partners, specializing in acquiring struggling or "zombie" biotech firms—often after these firms have discontinued their lead clinical programs. Recent acquisitions include Kronos Bio and Elevation Oncology. The strategy typically involves winding down operations, liquidating remaining assets, and returning cash to shareholders rather than advancing drug development[5][6][3].

Modalities: Small moleculeAntibody-drug conjugate
Industry: Investors

Beyond the preview

Go deeper on Concentra AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concentra AI.

Explore the full profile